1 |
0 |
|
|
How does the Jaccard index change from 6 months to 10 months? |
2 |
1 |
describe |
component |
Can you describe the key components of the sub-figure (f)? |
3 |
2 |
describe |
appearance |
Can you describe the appearance of tumor 1 and tumor 2? |
4 |
3 |
look |
|
How does the liver tissue of DBT-treated rats (G7) look like? |
5 |
4 |
describe |
feature |
Can you describe the features of sub-figure (c)? |
6 |
5 |
describe |
structure |
Can you describe the overall structure of the pituitary gland in the image? |
7 |
6 |
tell |
|
What can you tell me about the inflammation in sub-figure (D)? |
8 |
7 |
|
|
Are there any leads visible in the image? |
9 |
8 |
|
|
Is there any sign of inflammation or abnormality in the appendix? |
10 |
9 |
|
|
What about sub-figures (b) to (f)? What do they show? |
11 |
10 |
|
|
What about the staining pattern for p63? |
12 |
11 |
|
|
What about the chest X-ray image from day 42? |
13 |
12 |
provide |
|
And what information does sub-figure (D) provide? |
14 |
13 |
|
|
What about the changes in tumor density between the two rows? |
15 |
14 |
identify |
location |
Can you identify the location of the largest secondary peritoneal mass in the image? |
16 |
15 |
|
|
How about Section E? What are the main observations? |
17 |
16 |
describe |
aorta |
Can you describe the aorta at the level of the brachiocephalic trunk? |
18 |
17 |
|
|
What is the significance of generating 3D point clouds for each tissue region? |
19 |
18 |
describe |
location |
Can you describe the location of the tumor in segment I of the liver? |
20 |
19 |
appear |
|
How do the C6 tumors appear in the T2-weighted MR images compared to the 9L tumors? |
21 |
20 |
describe |
compression |
Can you describe the cord compression in the C5 to C7 levels? |
22 |
21 |
identify |
perforation |
How can you identify the gastric perforation in the image? |
23 |
22 |
|
|
Is there a scale or legend provided on the map? |
24 |
23 |
tell |
|
What can you tell me about the fusion of C7-T5 and T6-T7? |
25 |
24 |
tell |
|
What can you tell me about the areas of nodularity within the fluid collection? |
26 |
25 |
look |
|
What does the lung tissue look like in the image? |
27 |
26 |
|
|
How about the sub-figure at the 3-week time point? |
28 |
27 |
describe |
image |
Can you describe the whole mount staining images in more detail? |
29 |
28 |
|
|
Are there any other abnormalities visible in this chest X-ray? |
30 |
29 |
feature |
|
What features in the image lead to the suspicion of a tumor? |
31 |
30 |
describe |
feature |
Can you describe the stromal features in sub-figure (e)? |
32 |
31 |
|
|
What are the differences between CGL3 and CGL4 in the limb section? |
33 |
32 |
|
|
What about sub-figure B? What are the key findings? |
34 |
33 |
tell |
|
What can you tell me about sub-figures D1 and D2? |
35 |
34 |
|
|
What about the blue highlighted area? |
36 |
35 |
|
|
And what about sub-figure B3? |
37 |
36 |
compare |
|
How do the current opacities compare to the prior studies? |
38 |
37 |
|
|
What is the modality of the images in sub-figures (b) and (c)? |
39 |
38 |
|
|
What about the PAS staining in the HFSD group? |
40 |
39 |
describe |
location |
Can you describe the location of the pneumocephalus in the image? |
41 |
40 |
|
|
What was the initial MRI diagnosis for this case? |
42 |
41 |
describe |
appearance |
Can you describe the appearance of the enlarged right cochlear aqueduct in the image? |
43 |
42 |
|
|
What are the key components of the composite images in the 2nd row? |
44 |
43 |
|
|
How about the liver tissue? Are there any noticeable differences between the treatment groups? |
45 |
44 |
|
|
How about sub-figure 3e? What information does it provide? |
46 |
45 |
|
|
What about the location of the masticator space? |
47 |
46 |
|
|
Are there any specific brain regions that appear to be more affected in the moderate demented image? |
48 |
47 |
look |
|
What does the lichenoid infiltrate with necrotic keratinocytes look like in this image? |
49 |
48 |
describe |
silhouette |
Can you describe the cardiac silhouette in the image? |
50 |
49 |
tell |
|
Can you tell me what is depicted in sub-figure (c)? |
51 |
50 |
describe |
appearance |
Can you describe the appearance of the bone density mass? |
52 |
51 |
|
|
What about the teardrop sign? Can you describe it in more detail? |
53 |
52 |
describe |
contrast |
Can you describe the contrast between different structures in the image? |
54 |
53 |
stand |
|
What stands out or draws attention in the sub-figure F? |
55 |
54 |
|
|
What about the right image, the axial view? |
56 |
55 |
|
|
What is the context of this image? Why was it taken? |
57 |
56 |
|
|
How about the immunohistochemical analysis? What does sub-figure (e) show? |
58 |
57 |
describe |
appearance |
Can you describe the appearance of the blunt intestinal villi indicated by the arrows? |
59 |
58 |
|
|
What about the bone marrow sub-figure before the injection? |
60 |
59 |
describe |
system |
Can you describe the ventricular system in more detail? |
61 |
60 |
|
|
What is the final exclusion criterion? |
62 |
61 |
surround |
look |
How does the tissue surrounding the semi-permeable membrane look in the image? |
63 |
62 |
tell |
|
What can you tell me about the central veins in the image? |
64 |
63 |
tell |
|
Can you tell me more about the key components of sub-figure (C)? |
65 |
64 |
stand |
|
What stands out or draws attention in the top row images? |
66 |
65 |
describe |
position |
Can you describe the position of the chest drainage tube? |
67 |
66 |
describe |
appearance |
Can you describe the appearance of the opacity? |
68 |
67 |
describe |
difference |
Can you describe the differences between the control liver and the Alc+HFD-treated mice in the H&E staining? |
69 |
68 |
describe |
image |
Describe the SEM images in sub-figures (e), (i), and (m). |
70 |
69 |
look |
|
How does the adipose tissue look in comparison to the tumor cells? |
71 |
70 |
represent |
|
How is the epidural mass represented in the image? |
72 |
71 |
|
|
What is the function of the caudate nucleus (2)? |
73 |
72 |
look |
|
How does the bone marrow edema look in the image? |
74 |
73 |
describe |
sub |
Finally, can you describe the sixth sub-figure? |
75 |
74 |
identify |
bubble |
How can I identify the gastric bubble in the image? |
76 |
75 |
tell |
|
Finally, what can you tell me about the right upper sub-figure? |
77 |
76 |
describe |
appearance |
Can you describe the appearance of the bilateral lateral ventricles in the image? |
78 |
77 |
describe |
band |
Can you describe the delicate fibrous bands in more detail? |
79 |
78 |
describe |
trend |
Can you describe the trend in GDF-15 concentration as CVD severity increases? |
80 |
79 |
|
|
Is there any reference to color in the figure legend? |
81 |
80 |
stand |
|
What stands out or draws attention in the top left image? |
82 |
81 |
have |
result |
How many patients had valid results for TSPOT.TB, QFT-GIT, and PPD ELISPOT tests? |
83 |
82 |
happen |
|
What happens during the feature extraction stage? |
84 |
83 |
describe |
histology |
Can you describe the liver histology of the C57BL/6J mice (Nor)? |
85 |
84 |
|
|
Are there any significant findings in the CT scans? |
86 |
85 |
|
|
Where is the orogastric tube located? |
87 |
86 |
describe |
appearance |
Can you describe the appearance of the neurofibroma in the image? |
88 |
87 |
|
|
How about the macular shadows? What do they look like? |
89 |
88 |
|
|
How is the C4-C5 intervertebral disk space represented in the image? |
90 |
89 |
|
|
What about the thirteenth referral case? |
91 |
90 |
|
|
What are the most important or significant parts of the sub-figure (b)? |
92 |
91 |
|
|
How about sub-figure Bb? |
93 |
92 |
|
|
What are the cardiophrenic angles and how do they appear in this image? |
94 |
93 |
appear |
|
How does the pancreatic pseudocyst appear in the image? |
95 |
94 |
|
|
What about sub-figure (b)? What are the main aspects of it? |
96 |
95 |
represent |
|
What do the arrows in the top row represent? |
97 |
96 |
describe |
appearance |
Can you describe the appearance of the C5 vertebra in the image? |
98 |
97 |
describe |
|
Can you describe the H&E staining in more detail? |
99 |
98 |
do |
|
What does the higher magnification view of immunohistochemical features show? |
100 |
99 |
describe |
b3 |
Can you describe sub-figure B3? |